Latest filing published 12 Dec 2017 for CytomX Therapeutics, Inc., €6,842.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
William Michael Kavanaugh: trading record in brief
William Michael Kavanaugh appears in our data through filings on CytomX Therapeutics, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 14 October 2015 to 8 December 2017, the count stands at 5 filings.
Market trades split into 1 purchase (€52k) and 1 sale (€1.0M). Taken together, the sales exceed the purchases by €949k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 3 option exercises. 2017 to date brings no purchases and 1 sale.
Most recently, on 12 December 2017, the filings show an option exercise worth €6,842 in CytomX Therapeutics, Inc. The last purchase on record was published on 16 October 2015, which is 4,042 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to William Michael Kavanaugh
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,130 shares@ US$1.570.6% of flowCommon StockSEC:0001140361-17-045842:0
- 48,368 shares@ US$4.4715.4% of flowCommon StokSEC:0001140361-17-037761:0
- 48,368 shares@ US$24.3484.0% of flowCommon StockSEC:0001140361-17-037761:1
- 8,917 shares@ US$6.61Common StockSEC:0001140361-15-046030:0
4 of 4 declarations